Dihydroproscar
98%
Reagent
Code: #92893
Alias
N-tert-butyl-3-oxo-4-aza-5Α-androst-17Β-carboxamide; F9 / FINASTERIDE INTERMEDIATE; F9(3-keto-4-aza-5Α-androst-17Β-tert Butanamide) (127,000 ); N-tert-butyl-3-oxo-4-aza-5alpha-androst-17beta-carboxamide; Dihydroposcar (finasteride intermediate); 3-Oxo- 4-aza-5α-androstane-17β-(N-t-butylcarboxamide);
CAS Number
98319-24-5
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
374.56 g/mol
Formula
C₂₃H₃₈N₂O₂
badge
Registry Numbers
MDL Number
MFCD00214352
thermostat
Physical Properties
Boiling Point
569.397ºC
inventory_2
Storage & Handling
Density
1.051g/cm3
Storage
-20°C
description Product Description
Used primarily in the treatment of benign prostatic hyperplasia (BPH), it helps reduce the size of an enlarged prostate, alleviating symptoms such as difficulty in urination. It works by inhibiting the enzyme responsible for converting testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. Additionally, it is sometimes prescribed to lower the risk of urinary retention and the need for prostate surgery. It may also be used in combination with other medications for managing hair loss in men, as DHT is linked to male pattern baldness. Regular monitoring is advised to assess its effectiveness and manage potential side effects.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | White Solid |
| Purity | 98-100 |
| Infrared Spectrum | Conforms to Structure |
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB